The most commonly reported adverse events in patients treated with DULOXETINE BOEHRINGER INGELHEIM in clinical trials in SUI and other lower urinary tract disorders were nausea, dry mouth fatigue and constipation.
DULOXETINE BOEHRINGER INGELHEIM’ ga ravitud patsientide kõige sagedasemad kõrvaltoimed SUI ja teiste alumise urotrakti häirete kliinilistes uuringutes olid iiveldus, suukuivus, väsimus ja kõhukinnisus.